- Home
- SDA vs LAB Comparison
SDA vs LAB Comparison
Compare SDA & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SDA | LAB |
|---|---|---|
| Founded | 2007 | 1999 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 213.5M | 449.9M |
| IPO Year | N/A | 2011 |
Fundamental Metrics
Financial Performance| Metric | SDA | LAB |
|---|---|---|
| Price | $1.98 | $1.54 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 2 |
| Target Price | ★ $4.75 | $1.35 |
| AVG Volume (30 Days) | 80.0K | ★ 1.9M |
| Earning Date | 10-27-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $461,120,000.00 | $169,737,000.00 |
| Revenue This Year | $10.86 | N/A |
| Revenue Next Year | $13.07 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 13.17 | ★ 79.77 |
| 52 Week Low | $1.54 | $0.92 |
| 52 Week High | $10.61 | $2.25 |
Technical Indicators
Market Signals| Indicator | SDA | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 49.07 | 65.84 |
| Support Level | $1.82 | $1.44 |
| Resistance Level | $2.18 | $1.51 |
| Average True Range (ATR) | 0.12 | 0.07 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 34.22 | 79.41 |
Price Performance
Historical ComparisonAbout SDA SunCar Technology Group Inc.
SunCar Technology Group Inc operates digital automotive aftersales market service platform and vehicle insurance technology platform. It develops and operates online platforms that connect drivers in China with a range of aftermarket automotive services and insurance coverage options from a nationwide network of service providers. These comprehensive digital systems are built on SunCar's multi-tenant, cloud-based platform.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.